Related Experiment Video
Updated: May 27, 2025

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
Accurate Characterization of the Allosteric Energy Landscapes, Binding Hotspots and Long-Range Communications for
Abstract:
KRAS is a pivotal oncoprotein that regulates cell proliferation and survival through interactions with downstream effectors such as RAF1. Oncogenic mutations in KRAS, including G12V, G13D, and Q61R, drive constitutive activation and hyperactivation of signaling pathways, contributing to cancer progression. Despite significant advances in understanding KRAS biology, the structural and dynamic mechanisms of KRAS binding and allostery by which oncogenic mutations enhance KRAS-RAF1 binding and signaling remain incompletely understood. In this study, we employ microsecond molecular dynamics simulations, Markov State Modeling, mutational scanning and binding free energy calculations together with dynamic network modeling to elucidate the effect of KRAS mutations and characterize the thermodynamic and allosteric drivers and hotspots of KRAS binding and oncogenic activation. Our simulations revealed that oncogenic mutations stabilize the open active conformation of KRAS by differentially modulating the flexibility of the switch I and switch II regions, thereby enhancing RAF1 binding affinity. The G12V mutation rigidifies both switch I and switch II, locking KRAS in a stable, active state. In contrast, the G13D mutation moderately reduces switch I flexibility while increasing switch II dynamics, restoring a balance between stability and flexibility. The Q61R mutation induces a more complex conformational landscape, characterized by the increased switch II flexibility and expansion of functional macrostates, which promotes prolonged RAF1 binding and signaling. Mutational scanning of KRAS-RAF1 complexes identified key binding affinity hotspots, including Y40, E37, D38, and D33, and together with the MM-GBSA analysis revealed the hotspots leverage synergistic electrostatic and hydrophobic binding interactions in stabilizing the KRAS-RAF1 complexes. Network-based analysis of allosteric communication identifies critical KRAS residues (e.g., L6, E37, D57, R97) that mediate long-range interactions between the KRAS core and the RAF1 binding interface. The central β-sheet of KRAS emerges as a hub for transmitting conformational changes, linking distant functional sites and facilitating allosteric regulation. Strikingly, the predicted allosteric hotspots align with experimentally identified allosteric binding hotspots that define the energy landscape of KRAS allostery. This study highlights the power of integrating computational modeling with experimental data to unravel the complex dynamics of KRAS and its mutants. The identification of binding hotspots and allosteric communication routes offers new opportunities for developing targeted therapies to disrupt KRAS-RAF1 interactions and inhibit oncogenic signaling. Our results underscore the potential of computational approaches to guide the design of allosteric inhibitors and mutant-specific therapies for KRAS-driven cancers.
Insights
Oncogenic KRAS mutations stabilize active conformations, enhancing RAF1 binding and cancer signaling. Computational modeling reveals key binding hotspots and allosteric routes for targeted therapy development against KRAS-driven cancers.
Area of Science:
- Molecular biology and structural bioinformatics
- Computational biophysics and systems biology
Background:
- KRAS is a key oncoprotein regulating cell growth; oncogenic mutations (G12V, G13D, Q61R) lead to constitutive activation and cancer.
- Understanding the structural and dynamic mechanisms of KRAS-RAF1 interactions and allosteric regulation by mutations is crucial for therapeutic development.
Purpose of the Study:
- To elucidate the structural and dynamic effects of KRAS mutations on RAF1 binding and signaling using advanced computational methods.
- To identify thermodynamic and allosteric drivers, as well as binding hotspots, of KRAS oncogenic activation.
Main Methods:
- Microsecond molecular dynamics simulations and Markov State Modeling to analyze KRAS conformational dynamics.
- Mutational scanning, binding free energy calculations (MM-GBSA), and dynamic network modeling to identify binding hotspots and allosteric communication pathways.
- Integration of computational findings with experimental data.
Main Results:
- Oncogenic KRAS mutations stabilize active conformations by modulating switch I/II flexibility, enhancing RAF1 binding.
- Specific mutations (G12V, G13D, Q61R) induce distinct conformational changes affecting stability and dynamics.
- Identification of key binding hotspots (e.g., Y40, E37) and critical allosteric residues (e.g., L6, D57) mediating KRAS-RAF1 interactions.
Conclusions:
- Computational modeling reveals how KRAS mutations alter protein dynamics to enhance oncogenic signaling.
- Identified binding and allosteric hotspots provide potential targets for developing novel KRAS-specific therapies.
- This study demonstrates the power of integrating computational and experimental approaches for understanding KRAS biology and guiding drug design.
More Related Videos
Related Concept Videos
Cooperative Allosteric Transitions
Allosteric Regulation
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Ligand Binding and Linkage
MAPK Signaling Cascades
Protein Dynamics in Living Cells
Fluorescent recovery after photobleaching (FRAP) is a fluorescent-protein-based detection technique used to quantify protein movement rates within the cell. This method exposes a small portion of the cell to an intense laser beam. The laser beam causes permanent photobleaching of the fluorophore-tagged proteins in the exposed region. As the bleached...

